Author

Anas Mansour

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Cardiovascular outcomes of SGLT2 inhibitors across the spectrum of myocardial infarction: A systematic review and meta-analysis.

AIMS Sodium-glucose cotransporter-2 inhibitors (SGLT2i) help in heart failure (HF), but their benefit after acute myocardial infarction is unclear. This meta-analysis assesses their impact on mortality and heart failure hospitalization post-acute myocardial infarction (AMI) and identifies which patients benefit most....

Ahmed Elazab, Ahmed Elbataa, A. Mansour et al. · British Journal of Clinical... · 0 citations

Review Open access Sep 2026

Melatonin supplementation in multiple sclerosis: a systematic review of clinical, imaging, biomarker, and safety outcomes

Current evidence does not support a disease-modifying effect of melatonin in MS, and any symptomatic or biomarker benefits need confirmation in larger, well-designed trials, and high-dose melatonin may carry meaningful hepatic risk.

Yehia Nabil, A. Ghazou, Sara Abodabesh et al. · Frontiers in Neurology · 0 citations

Review Sep 2026

Clinical Outcomes of Conduction System versus Right Ventricular Pacing after TAVR: A Systematic Review and Meta-Analysis.

The potential clinical relevance of CSP when a high ventricular pacing burden is anticipated remains plausible but was not directly demonstrated by the available data; adequately powered randomized trials are required before routine adoption.

R. Shakeel, A. Uddin, D. Ladhani et al. · Pacing and clinical electrop... · 0 citations